HEADER TRANSFERASE 29-AUG-02 1IYK TITLE CRYSTAL STRUCTURE OF CANDIDA ALBICANS N-MYRISTOYLTRANSFERASE WITH TITLE 2 MYRISTOYL-COA AND PEPTIDIC INHIBITOR CAVEAT 1IYK THE LIGAND MYA HAS WRONG GEOMETRY. COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYRISTOYL-COA:PROTEIN N-MYRISTOYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 60-451; COMPND 5 SYNONYM: GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE; COMPND 6 EC: 2.3.1.97; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS; SOURCE 3 ORGANISM_TAXID: 5476; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PKF19 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SOGABE,T.A.FUKAMI,K.MORIKAMI,Y.SHIRATORI,Y.AOKI,A.D'ARCY, AUTHOR 2 F.K.WINKLER,D.W.BANNER,T.OHTSUKA REVDAT 5 27-DEC-23 1IYK 1 REMARK REVDAT 4 09-NOV-11 1IYK 1 CAVEAT REVDAT 3 13-JUL-11 1IYK 1 VERSN REVDAT 2 24-FEB-09 1IYK 1 VERSN REVDAT 1 30-DEC-02 1IYK 0 JRNL AUTH S.SOGABE,M.MASUBUCHI,K.SAKATA,T.A.FUKAMI,K.MORIKAMI, JRNL AUTH 2 Y.SHIRATORI,H.EBIIKE,K.KAWASAKI,Y.AOKI,N.SHIMMA,A.D'ARCY, JRNL AUTH 3 F.K.WINKLER,D.W.BANNER,T.OHTSUKA JRNL TITL CRYSTAL STRUCTURES OF CANDIDA ALBICANS JRNL TITL 2 N-MYRISTOYLTRANSFERASE WITH TWO DISTINCT INHIBITORS JRNL REF CHEM.BIOL. V. 9 1119 2002 JRNL REFN ISSN 1074-5521 JRNL PMID 12401496 JRNL DOI 10.1016/S1074-5521(02)00240-5 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.2 REMARK 3 NUMBER OF REFLECTIONS : 41433 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2096 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 41433 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 72.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5087 REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 248 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6420 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 212 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.560 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.390 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.280 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.090 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.28 REMARK 3 BSOL : 18.61 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1IYK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-AUG-02. REMARK 100 THE DEPOSITION ID IS D_1000005410. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-NOV-96 REMARK 200 TEMPERATURE (KELVIN) : 288 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-6B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : DIFFRACTOMETER REMARK 200 DETECTOR MANUFACTURER : WEISSENBERG REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41498 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.3 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.26800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, AMMONIUM ACETATE, HEPES, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.34800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 88.27450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.66700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 88.27450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.34800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.66700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 10060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -70.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 171 -155.88 -135.19 REMARK 500 ILE A 215 79.77 -66.16 REMARK 500 LEU A 216 144.27 169.60 REMARK 500 THR A 218 80.99 43.68 REMARK 500 HIS A 307 89.17 -69.27 REMARK 500 ASP A 308 67.72 -55.81 REMARK 500 GLU A 309 -101.33 -72.05 REMARK 500 SER A 311 -162.78 62.53 REMARK 500 ASP A 312 66.38 63.93 REMARK 500 PHE A 356 -118.21 -107.08 REMARK 500 GLN A 397 -141.63 52.71 REMARK 500 TYR A 422 116.77 -170.90 REMARK 500 ASP B 136 0.91 -67.67 REMARK 500 SER B 171 -150.55 -152.32 REMARK 500 SER B 214 49.51 -80.34 REMARK 500 ILE B 215 -61.37 -95.65 REMARK 500 THR B 218 86.89 41.23 REMARK 500 THR B 221 176.08 178.68 REMARK 500 ASP B 323 -168.01 -75.42 REMARK 500 PHE B 356 -113.24 -105.61 REMARK 500 GLN B 397 -130.26 51.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYA A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MIM A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MYA B 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MIM B 1502 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IYL RELATED DB: PDB REMARK 900 1IYL CONTAINS THE SAME PROTEIN WITH NON-PEPTIDIC INHIBITOR DBREF 1IYK A 60 451 UNP P30418 NMT_CANAL 60 451 DBREF 1IYK B 60 451 UNP P30418 NMT_CANAL 60 451 SEQRES 1 A 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 A 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 A 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 A 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 A 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 A 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 A 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 A 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 A 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 A 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 A 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 A 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 A 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 A 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 A 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 A 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 A 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 A 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 A 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 A 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 A 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 A 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 A 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 A 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 A 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 A 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 A 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 A 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 A 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 A 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 A 392 LEU LEU SEQRES 1 B 392 GLU GLY PRO ILE ASP LYS LEU LYS THR PRO GLU ASP VAL SEQRES 2 B 392 PRO ASN ASP PRO LEU PRO LEU ILE SER ASP PHE GLU TRP SEQRES 3 B 392 SER THR LEU ASP ILE ASP ASP ASN LEU GLN LEU ASP GLU SEQRES 4 B 392 LEU TYR LYS LEU LEU TYR ASP ASN TYR VAL GLU ASP ILE SEQRES 5 B 392 ASP ALA THR PHE ARG PHE LYS TYR SER HIS GLU PHE PHE SEQRES 6 B 392 GLN TRP ALA LEU LYS PRO PRO GLY TRP ARG LYS ASP TRP SEQRES 7 B 392 HIS VAL GLY VAL ARG VAL LYS SER THR GLY LYS LEU VAL SEQRES 8 B 392 ALA PHE ILE ALA ALA THR PRO VAL THR PHE LYS LEU ASN SEQRES 9 B 392 LYS SER ASN LYS VAL ILE ASP SER VAL GLU ILE ASN PHE SEQRES 10 B 392 LEU CYS ILE HIS LYS LYS LEU ARG ASN LYS ARG LEU ALA SEQRES 11 B 392 PRO VAL LEU ILE LYS GLU ILE THR ARG ARG VAL ASN LYS SEQRES 12 B 392 GLN ASN ILE TRP GLN ALA LEU TYR THR GLY GLY SER ILE SEQRES 13 B 392 LEU PRO THR PRO LEU THR THR CYS ARG TYR GLN HIS ARG SEQRES 14 B 392 PRO ILE ASN TRP SER LYS LEU HIS ASP VAL GLY PHE SER SEQRES 15 B 392 HIS LEU PRO PRO ASN GLN THR LYS SER SER MET VAL ALA SEQRES 16 B 392 SER TYR THR LEU PRO ASN ASN PRO LYS LEU LYS GLY LEU SEQRES 17 B 392 ARG PRO MET THR GLY LYS ASP VAL SER THR VAL LEU SER SEQRES 18 B 392 LEU LEU TYR LYS TYR GLN GLU ARG PHE ASP ILE VAL GLN SEQRES 19 B 392 LEU PHE THR GLU GLU GLU PHE LYS HIS TRP MET LEU GLY SEQRES 20 B 392 HIS ASP GLU ASN SER ASP SER ASN VAL VAL LYS SER TYR SEQRES 21 B 392 VAL VAL GLU ASP GLU ASN GLY ILE ILE THR ASP TYR PHE SEQRES 22 B 392 SER TYR TYR LEU LEU PRO PHE THR VAL LEU ASP ASN ALA SEQRES 23 B 392 GLN HIS ASP GLU LEU GLY ILE ALA TYR LEU PHE TYR TYR SEQRES 24 B 392 ALA SER ASP SER PHE GLU LYS PRO ASN TYR LYS LYS ARG SEQRES 25 B 392 LEU ASN GLU LEU ILE THR ASP ALA LEU ILE THR SER LYS SEQRES 26 B 392 LYS PHE GLY VAL ASP VAL PHE ASN CYS LEU THR CYS GLN SEQRES 27 B 392 ASP ASN THR TYR PHE LEU LYS ASP CYS LYS PHE GLY SER SEQRES 28 B 392 GLY ASP GLY PHE LEU ASN TYR TYR LEU PHE ASN TYR ARG SEQRES 29 B 392 THR PHE PRO MET ASP GLY GLY ILE ASP LYS LYS THR LYS SEQRES 30 B 392 GLU VAL VAL GLU ASP GLN THR SER GLY ILE GLY VAL VAL SEQRES 31 B 392 LEU LEU HET MYA A 501 63 HET MIM A 502 43 HET MYA B1501 63 HET MIM B1502 43 HETNAM MYA TETRADECANOYL-COA HETNAM MIM [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL-1-IMIDAZOLYL- HETNAM 2 MIM BUTYL]PHENYL]ACETYL]-SERYL]-LYSINYL]-AMINE HETSYN MYA MYRISTOYL-COA FORMUL 3 MYA 2(C35 H62 N7 O17 P3 S) FORMUL 4 MIM 2(C33 H52 N6 O4) FORMUL 7 HOH *123(H2 O) HELIX 1 1 THR A 68 VAL A 72 5 5 HELIX 2 2 ASP A 92 TYR A 107 1 16 HELIX 3 3 SER A 120 LYS A 129 1 10 HELIX 4 4 ARG A 134 ASP A 136 5 3 HELIX 5 5 LYS A 181 ARG A 184 5 4 HELIX 6 6 LEU A 188 LYS A 202 1 15 HELIX 7 7 ASN A 231 VAL A 238 1 8 HELIX 8 8 THR A 248 THR A 257 1 10 HELIX 9 9 THR A 271 LYS A 273 5 3 HELIX 10 10 ASP A 274 GLU A 287 1 14 HELIX 11 11 THR A 296 GLY A 306 1 11 HELIX 12 12 ASN A 367 LYS A 384 1 18 HELIX 13 13 LYS A 385 GLY A 387 5 3 HELIX 14 14 ASP A 398 PHE A 402 5 5 HELIX 15 15 THR B 68 VAL B 72 5 5 HELIX 16 16 ASP B 92 TYR B 107 1 16 HELIX 17 17 SER B 120 LEU B 128 1 9 HELIX 18 18 ARG B 134 ASP B 136 5 3 HELIX 19 19 LYS B 181 ARG B 184 5 4 HELIX 20 20 LEU B 188 LYS B 202 1 15 HELIX 21 21 ASN B 231 VAL B 238 1 8 HELIX 22 22 THR B 248 THR B 257 1 10 HELIX 23 23 ASP B 274 GLU B 287 1 14 HELIX 24 24 THR B 296 GLY B 306 1 11 HELIX 25 25 SER B 362 LYS B 365 5 4 HELIX 26 26 ASN B 367 SER B 383 1 17 HELIX 27 27 LYS B 384 GLY B 387 5 4 HELIX 28 28 ASP B 398 PHE B 402 5 5 SHEET 1 A 4 LYS A 167 ILE A 179 0 SHEET 2 A 4 LEU A 149 LEU A 162 -1 N VAL A 158 O SER A 171 SHEET 3 A 4 HIS A 138 VAL A 143 -1 N VAL A 141 O VAL A 150 SHEET 4 A 4 PHE A 83 THR A 87 -1 N GLU A 84 O ARG A 142 SHEET 1 B 4 LYS A 167 ILE A 179 0 SHEET 2 B 4 LEU A 149 LEU A 162 -1 N VAL A 158 O SER A 171 SHEET 3 B 4 ILE A 291 LEU A 294 -1 O VAL A 292 N LYS A 161 SHEET 4 B 4 ILE A 446 GLY A 447 1 O GLY A 447 N ILE A 291 SHEET 1 C 3 PHE A 115 PHE A 117 0 SHEET 2 C 3 PHE A 339 VAL A 341 -1 O THR A 340 N ARG A 116 SHEET 3 C 3 GLU A 349 LEU A 350 -1 O LEU A 350 N PHE A 339 SHEET 1 D 8 ALA A 208 GLY A 212 0 SHEET 2 D 8 GLY A 409 PHE A 420 -1 O TYR A 418 N TYR A 210 SHEET 3 D 8 THR A 221 PRO A 229 -1 N HIS A 227 O GLY A 409 SHEET 4 D 8 VAL A 390 LEU A 394 -1 O CYS A 393 N GLN A 226 SHEET 5 D 8 ILE A 352 SER A 360 1 N ALA A 353 O ASN A 392 SHEET 6 D 8 ILE A 328 LEU A 336 -1 N TYR A 335 O TYR A 354 SHEET 7 D 8 VAL A 316 GLU A 322 -1 N TYR A 319 O PHE A 332 SHEET 8 D 8 LEU A 267 PRO A 269 -1 N ARG A 268 O VAL A 320 SHEET 1 E12 LEU B 267 PRO B 269 0 SHEET 2 E12 VAL B 316 GLU B 322 -1 O VAL B 320 N ARG B 268 SHEET 3 E12 ILE B 328 LEU B 336 -1 O THR B 329 N VAL B 321 SHEET 4 E12 ILE B 352 SER B 360 -1 O TYR B 354 N TYR B 335 SHEET 5 E12 VAL B 390 LEU B 394 1 O ASN B 392 N ALA B 353 SHEET 6 E12 THR B 221 PRO B 229 -1 N ARG B 228 O PHE B 391 SHEET 7 E12 GLY B 409 PHE B 420 -1 O GLY B 409 N HIS B 227 SHEET 8 E12 ALA B 208 GLY B 212 -1 N TYR B 210 O TYR B 418 SHEET 9 E12 LYS B 167 ILE B 179 1 N VAL B 172 O LEU B 209 SHEET 10 E12 LEU B 149 LEU B 162 -1 N VAL B 158 O SER B 171 SHEET 11 E12 HIS B 138 VAL B 143 -1 N VAL B 141 O VAL B 150 SHEET 12 E12 PHE B 83 THR B 87 -1 N GLU B 84 O ARG B 142 SHEET 1 F12 LEU B 267 PRO B 269 0 SHEET 2 F12 VAL B 316 GLU B 322 -1 O VAL B 320 N ARG B 268 SHEET 3 F12 ILE B 328 LEU B 336 -1 O THR B 329 N VAL B 321 SHEET 4 F12 ILE B 352 SER B 360 -1 O TYR B 354 N TYR B 335 SHEET 5 F12 VAL B 390 LEU B 394 1 O ASN B 392 N ALA B 353 SHEET 6 F12 THR B 221 PRO B 229 -1 N ARG B 228 O PHE B 391 SHEET 7 F12 GLY B 409 PHE B 420 -1 O GLY B 409 N HIS B 227 SHEET 8 F12 ALA B 208 GLY B 212 -1 N TYR B 210 O TYR B 418 SHEET 9 F12 LYS B 167 ILE B 179 1 N VAL B 172 O LEU B 209 SHEET 10 F12 LEU B 149 LEU B 162 -1 N VAL B 158 O SER B 171 SHEET 11 F12 ILE B 291 LEU B 294 -1 O VAL B 292 N LYS B 161 SHEET 12 F12 ILE B 446 GLY B 447 1 O GLY B 447 N ILE B 291 SHEET 1 G 3 PHE B 115 PHE B 117 0 SHEET 2 G 3 PHE B 339 VAL B 341 -1 O THR B 340 N ARG B 116 SHEET 3 G 3 GLU B 349 LEU B 350 -1 O LEU B 350 N PHE B 339 SITE 1 AC1 21 TYR A 107 VAL A 108 PHE A 176 LEU A 177 SITE 2 AC1 21 CYS A 178 ILE A 179 ARG A 184 ASN A 185 SITE 3 AC1 21 LYS A 186 ARG A 187 LEU A 188 ALA A 189 SITE 4 AC1 21 PRO A 190 THR A 197 TRP A 206 GLN A 207 SITE 5 AC1 21 TYR A 210 THR A 211 LEU A 216 PHE A 420 SITE 6 AC1 21 HOH A 513 SITE 1 AC2 22 VAL A 108 GLU A 109 ASP A 110 ASP A 112 SITE 2 AC2 22 PHE A 117 TYR A 119 ASN A 175 THR A 211 SITE 3 AC2 22 TYR A 225 HIS A 227 PHE A 240 TYR A 256 SITE 4 AC2 22 GLY A 409 SER A 410 GLY A 411 ASP A 412 SITE 5 AC2 22 GLY A 413 LEU A 415 LEU A 451 HOH A 507 SITE 6 AC2 22 HOH A 517 HOH A 526 SITE 1 AC3 24 TYR B 107 VAL B 108 ILE B 174 PHE B 176 SITE 2 AC3 24 LEU B 177 CYS B 178 ILE B 179 ARG B 184 SITE 3 AC3 24 ASN B 185 LYS B 186 ARG B 187 LEU B 188 SITE 4 AC3 24 ALA B 189 PRO B 190 THR B 197 ASN B 201 SITE 5 AC3 24 TRP B 206 ALA B 208 TYR B 210 THR B 211 SITE 6 AC3 24 ILE B 215 LEU B 216 PHE B 420 HOH B1509 SITE 1 AC4 23 VAL B 108 GLU B 109 ASP B 110 ILE B 111 SITE 2 AC4 23 ASP B 112 PHE B 115 PHE B 117 ASN B 175 SITE 3 AC4 23 THR B 211 TYR B 225 HIS B 227 PHE B 240 SITE 4 AC4 23 TYR B 256 PHE B 339 GLY B 409 SER B 410 SITE 5 AC4 23 GLY B 411 ASP B 412 GLY B 413 LEU B 415 SITE 6 AC4 23 LEU B 451 HOH B1525 HOH B1532 CRYST1 58.696 95.334 176.549 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017037 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010489 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005664 0.00000